


Vol 73, No 5 (2024)
- Year: 2024
- Published: 04.12.2024
- Articles: 16
- URL: https://journals.eco-vector.com/jowd/issue/view/9346
- DOI: https://doi.org/10.17816/JOWD.735
Original study articles
Determination of antimicrobial resistance genes in patients with infected miscarriage. A rapid identification and optimized empirical therapy
Abstract
BACKGROUND: The infectious factor during pregnancy remains the leading cause not only of maternal mortality, but also of premature pregnancy loss and subsequent reproductive function impairment. Patients with infected miscarriage represent a special cohort in terms of complexity of clinical decision-making, while the choice of antimicrobial chemotherapy is particularly difficult in conditions of accumulation of scientific knowledge about the main microbial agents. For adequate treatment, it is essential to use all modern methods of microbiota diagnosis and conduct regular monitoring of microorganism resistance in order to update empirical schemes of antibacterial therapy.
AIM: The aim of this study was to evaluate the correlation relationship between antimicrobial resistance genes and identified microbial agents in patients with infected miscarriage in order to optimize empirical antimicrobial chemotherapy.
MATERIALS AND METHODS: We prospectively studied 42 samples of genital tract discharge in patients with infected miscarriage. The classical culture method was used to determine microorganism sensitivity to standard antibacterial drugs by the disc diffusion test. A molecular genetic study of the species composition of clinically significant microbial agents and genes of resistance to β-lactam and glycopeptide antibiotics was performed using Femoflor Screen and BakRezista GLA test systems (“DNA-Technology” LLC., Russia), respectively.
RESULTS: In the cultural study, one microbial agent was identified in 59.5% of cases, two in 40.0% of cases, and three in 7.1% of cases. The following microorganisms were most frequently identified: Enterococcus spp. in 25.0% of cases, Esherichia coli in 16.7% of cases, and Candida spp. in 11.7% of cases. During the molecular genetic study, Lactobacillus spp. were identified in 64.3% of the samples, the microorganisms associated with bacterial vaginosis in 45.3% of the samples, Candida spp. in 23.8% of the samples, and Herpesviridae family viruses in 14.3% of the samples. In 45.2% of the samples, one to 14 genes of resistance to β-lactam and glycopeptide antibiotics were identified, while Tem (19.0%), Oxa-40-like (19.0%), Stx-M1 (14.3%), Ges (14.3%), Oxa-51-like (11.9%), and Van A/B (9.5%) were most frequently determined in the samples positive for resistance genes. Comparison between phenotypic susceptibility testing and genetic prediction for antibiotics resistance demonstrated that the specificity varied from 96.4 to 100%, and the sensitivity from 40.0 to 85.7%.
CONCLUSIONS: The use of molecular genetic diagnostic methods allows for the identification of clinically significant urogenital tract infections and the detection of markers of their resistance to β-lactam antibiotics and glycopeptides in the shortest possible time. The data obtained make it possible to optimize the initial antimicrobial chemotherapy.



In vitro model of premature ovarian insufficiency based on cyclophosphamide-induced mitochondrial dysfunction in granulosa cells
Abstract
BACKGROUND: Currently, there is no unified approach or effective method for treating premature ovarian insufficiency. The primary strategy is hormone replacement therapy aimed at mitigating estrogen deficiency and its associated complications. However, this therapy does not restore lost ovarian function or fertility. Thus, further research into the pathogenesis of premature ovarian insufficiency is crucial for developing alternative pathogenetically based therapies. Investigating the efficacy of various drugs in preclinical trials using cellular models holds significant promise. Experimental modeling of premature ovarian insufficiency, which closely replicates the origin and development mechanism of the human disease, can be effectively used to develop promising therapeutic approaches, in particular, for testing new drugs.
AIM: The aim of this study was to develop a new method for experimental modeling of premature ovarian insufficiency using cyclophosphamide in Wistar rats, the significant advantages of which are high reproducibility, ease of implementation, and cost-effectiveness.
MATERIALS AND METHODS: A culture of Wistar rat ovarian granulosa cells after five stages of subculturing was treated with the drug cyclophosphamide, ensuring a working concentration in the growth medium of 0.1 mg/ml, followed by incubation for six hours.
RESULTS: A cellular model of premature ovarian insufficiency has been created, which is characterized by 100% modeling efficiency, high manufacturability and environmental safety for modeling the pathological condition.
CONCLUSIONS: The model created will allow for testing the medicinal effectiveness of chemicals with a view to their further use in medicine.



Organ-preserving laparoscopic myomectomy in atypical leiomyoma arrangement
Abstract
BACKGROUND: Uterine fibroids are the most common cause of surgical treatment in women and total hysterectomy is performed in most cases to radically solve this problem. The organ-preserving approach aims to preserve fertility and the ability to reproduce in patients of reproductive age. The atypical location of leiomyomas complicates the possibility of performing an organ-preserving myomectomy.
AIM: The aim of this study was to assess the possibility of performing myomectomy for atypical leiomyoma using laparoscopic access in routine practice to preserve fertility and implement reproductive plans.
MATERIALS AND METHODS: This study included 213 patients of reproductive age with uterine fibroids. Myomectomy for typical or atypical leiomyomas was performed by laparoscopic access. A comparative analysis of surgical treatment and perioperative management of patients with atypically located fibroids and fibroids of other localization was carried out. The results of the achievement by the patients of their reproductive goals were evaluated. The duration of follow-up was 24 months.
RESULTS: Atypical node location was noted in 65 (30.5%) cases. When comparing the duration of surgical treatment, volume of blood loss, need for analgesics, presence of intraoperative and postoperative complications, duration of hospitalization and recovery period in patients with atypical leiomyoma, these parameters did not differ from those in the surgical treatment of patients with typical leiomyoma. Anatomical and functional results of surgical treatment were analyzed after one, three, six, 12, and 24 months. Of the 70 patients planning pregnancy, 26 (37%) women became pregnant on average 8.3 months after surgery. The location of the removed fibroids was atypical in ten cases.
CONCLUSIONS: The atypical location of leiomyoma does not affect the course of the surgical and postoperative periods and long-term results of surgical treatment. The possibility of routine organ-preserving treatment by laparoscopic access in patients with atypical fibroids leaves prospects for the implementation of the woman’s reproductive plans.



Endothelial microvesicles in peripheral blood of pregnant women with preeclampsia
Abstract
BACKGROUND: Endothelial dysfunction is the leading pathogenetic factor of preeclampsia. The function of the endothelium may be reflected in its ability to form microvesicles, which are generated by cells through the regulated shedding of the plasma membrane.
AIM: The aim of this study was to evaluate the endothelial microvesicles count in peripheral blood of women with normal pregnancy and pregnancy complications such as gestational arterial hypertension and severe preeclampsia.
MATERIALS AND METHODS: This study included 72 individuals, of whom there were healthy non-pregnant women (n = 21), women with normal pregnancy (n = 20), pregnant women with gestational arterial hypertension (n = 24), and pregnant women with severe preeclampsia (n = 7). To isolate microvesicles from peripheral blood, the differential centrifugation method was used. Microvesicles were treated with antibodies to vascular endothelial growth factor receptors (VEGFR1, VEGFR2), CD41a, CD34, and CD31 conjugated to fluorochromes. The absolute and relative count of microvesicles, as well as the fluorescence intensity, were analyzed using a BD FACSCanto II cytofluorimeter.
RESULTS: In normal pregnancy, the count of microvesicles with the VEGFR1+, VEGFR2+, CD31+, and CD34+ phenotype was increased compared to non-pregnant women. In gestational arterial hypertension compared to normal pregnancy, no differences were found in the endothelial microvesicles count and endothelial marker expression. In severe preeclampsia, the total microvesicles count and endothelial cell derived microvesicles count in the peripheral blood plasma decreased in comparison with normal pregnancy and gestational arterial hypertension. While the expression of endothelial markers such as VEGFR1, VEGFR2, and CD34 in microvesicles membranes in severe preeclampsia increased compared to normal pregnancy and gestational arterial hypertension.
CONCLUSIONS: An increase in the endothelial microvesicles count in normal pregnancy may be associated with an increase in the vascular bed area due to placenta formation. A decrease in the endothelial microvesicles count in severe preeclampsia is associated with damage to the endothelium and disruption of its function. Increased expression of endothelial cell receptors on microvesicles in severe preeclampsia may reflect compensatory reactions of the endothelium during the above damage.



Clinical experience in the study of thrombodynamics in pregnant women at risk of developing preeclampsia and during its manifestation
Abstract
BACKGROUND: Need for early diagnosis of intravascular activation of coagulation in obstetric patients at risk of preeclampsia.
AIM: The aim of this study was to assess the diagnostic value of the thrombodynamics test in patients at risk of developing preeclampsia and during its manifestation.
MATERIALS AND METHODS: Dynamic thrombophotometry was performed in 56 pregnant women using a domestic “T2 Thrombodynamics Recorder” device (GemaKor Ltd., Russia). The first study group consisted of patients in the second to early third trimester of pregnancy (n = 45), who, due to hypercoagulability, according to the conventional coagulogram, received low-molecular-weight heparin therapy (calcium nadroparin 0.3 ml or enoxaparin sodium 0.4 ml subcutaneously). The thrombodynamics test was performed to evaluate the efficacy of anticoagulant therapy. The second study group involved patients with moderate (n = 11) and severe (n = 8) preeclampsia.
RESULTS: The test was effective in monitoring the state of the hemostasis system in pregnant women receiving anticoagulant therapy — despite normal coagulogram test parameters, the increased rate of fibrin clot formation and / or spontaneous clots indicated increased anticoagulant therapy in 37.8% of patients. Among patients with extragenital pathology, the incidence of spontaneous clots, which should not form during normal coagulation, was observed in all pregnant women with chronic arterial hypertension combined with obesity (χ2 = 6.11; p < 0.02), which characterizes the tendency to activate intravascular coagulation in such patients. Subsequently, moderate PE developed in 15.6% of pregnant women with predisposing extragenital pathology, there being no cases of severe preeclampsia. A comparison of thrombodynamics test parameters in patients with moderate and severe preeclampsia showed that in severe preeclampsia, there is a tendency to a higher rate of fibrin clot formation and a higher frequency of spontaneous clot formation (χ2 = 12.7; p < 0.01). The test demonstrated high sensitivity (81.8%) and specificity (97.4%) of signaling the presence of severe preeclampsia.
CONCLUSIONS: Demonstration of a clinical case of HELLP syndrome in a pregnant woman showed that confirmation of consumption thrombocytopenia due to activation of intravascular coagulation using the thrombodynamics test, in contrast to the global thromboelastography test and the conventional coagulogram test, allowed timely initiation of anticoagulant therapy and avoided the development of irreversible secondary microangiopathy.



Intrapartum maternal risks of group B streptococcus carriage in premature rupture of membranes
Abstract
BACKGROUND: Group B streptococcal infection remains the epicenter of attention for maternal and child health services around the world. Premature rupture of membranes requires adaptation of obstetric tactics and intrapartum antibiotic prophylaxis.
AIM: The aim of this study was to identify maternal intrapartum risks of group B streptococcus colonization of the birth canal and the lack of antepartum screening for group B streptococcus in cases of premature rupture of membranes in full-term pregnancy.
MATERIALS AND METHODS: This retrospective cohort study was conducted in the Perinatal Center of City Clinical Hospital No. 31 named after Academician G.M. Savelyeva (Moscow, Russia) in 2023–2024. We selected women with premature rupture of membranes at full-term pregnancy, whose birth canals were subsequently divided into those colonized by group B streptococcus and those not colonized and who underwent antenatal group B streptococcus screening at 35–37 weeks of pregnancy or not. In the absence of group B streptococcus screening upon admission to the hospital, vaginal discharge was collected and sent off for bacteriological testing. Two tactics for labor management were selected: expectant, and active. Intrapartum antibiotic prophylaxis was performed in case of group B streptococcus isolation during screening.
RESULTS: With premature rupture of membranes in full-term pregnancy, only 57.14% of group B streptococcus carriers have prenatal group B streptococcus screening; therefore, in 42.86% of group B streptococcus carriers, intrapartum antibiotic prophylaxis was delayed by 18 hours. Group B streptococcus carriage is not associated with the gestational age of premature rupture of membranes, but has intrapartum features such as a trend of younger age (less than 30 years) and attendance at the hospital earlier than six hours after premature rupture of membranes with the opportunity for induction or effective pre-induction of labor with a single dose of an antigestagen (in more than 70% of women). These women had a blood leukocyte count of ≥12.5 × 109/l and higher C-reactive protein levels. They were most often delivered by cesarean section, with characteristic indications for chorioamnionitis and fetal distress. The absence of prenatal group B streptococcus screening distinguishes the age of women under 30 years old, the threshold C-reactive protein level being 19.5 g/l, with a tendency towards a less frequent spontaneous onset of labor and a higher frequency of its induction, hypotonic hemorrhage, and chorioamnionitis.
CONCLUSIONS: There are intrapartum maternal risks of group B streptococcus carriage and the presence of group B streptococcus screening, which are conditionally controlled in the Moscow. Intrapartum antibiotic prophylaxis and the metropolis resource “equalize” the outcome of births in cases of group B streptococcus carriage and absence, with the presence and absence of group B streptococcus screening. Modern medicine allows for minimizing the risks of chorioamnionitis and hypotonic hemorrhage in group B streptococcus carriers after premature rupture of membranes, even in the absence of group B streptococcus screening in more than half of women or deferment of intrapartum antibiotic prophylaxis for 18 hours.



Analysis of the effectiveness of laparoscopic myomectomy using a standardized technique
Abstract
BACKGROUND: Uterine fibroids are a benign monoclonal tumor arising from myometrial smooth muscle cells and fibroblasts with the deposition of extracellular matrix components in response to vascular injury. Diagnosis of uterine fibroids is steadily growing every year due to the introduction of new and accessible research methods. At the moment, the preferred organ-preserving surgical method for treating uterine fibroids is laparoscopic myomectomy, which allows preserving reproductive function. Considering the high risk of intra- and postoperative bleeding during surgery, the development and use of blood-saving technologies remains relevant. This article contains results of the effectiveness of the surgical technique without performing the stage of vessel clipping, which involves assessing the volume of intraoperative blood loss and the duration of the operation.
AIM: The aim of this study was to analyze the effectiveness of using a standardized technique of laparoscopic myomectomy without uterine artery clipping.
MATERIALS AND METHODS: This study included 77 patients with symptomatic uterine fibroids who underwent surgical treatment in Gynecological Department I with Operating Unit, The Research Institute of Obstetrics, Gynecology and Reproductology named after D.O. Ott (St. Petersburg, Russia). Implying an assessment of the volume of intraoperative blood loss and the duration of the operation.
RESULTS: The average number of removed myomatous nodes was 2.2 ± 1.2 (from 1 to 11). The size of the removed fibroids averaged 5.1 ± 1.8 cm in diameter. At the same time, the minimum size of the remote node was 1.5 cm, and the maximum size was 15 cm. Intramural [International Federation of Gynecology and Obstetrics (FIGO) types 3 and 4] localization of myomatous nodes was found in 30 (17.6%) cases, intramural subserosal (FIGO type 5) in 45 (26.4%) cases, subserosal (FIGO type 6) in 54 (31.7%) cases, subserosal pedunculated (FIGO type 7) in 30 (17.6%) cases, and intramural submucosal and submucosal forms (FIGO types 0–2) in ten (5.8 %) cases. The average intraoperative blood loss was 187.7 ± 16.71 ml, average hemoglobin level in the postoperative period was 117.1 ± 13.15 g/l, with an initial level of 126 ± 12.1 g/l. The average duration of the operation was 95 ± 30.3 minutes, and the average bed-day was 8 ± 1.5.
CONCLUSIONS: The data obtained allow for drawing a reasonable conclusion about the effectiveness and safety of the standardized technique of laparoscopic myomectomy, developed in Gynecological Department I with Operating Unit, The Research Institute of Obstetrics, Gynecology and Reproductology named after D.O. Ott (Saint Petersburg, Russia), and for recommending its widespread use.



Dynamics of blood adipokine levels and their ratios in assisted reproductive technology programs depending on the clinical pregnancy onset
Abstract
BACKGROUND: The adipokines leptin, adiponectin, and ghrelin are expressed not only in adipose tissue but also in the hypothalamic-pituitary-gonadal axis organs and the uterus. They regulate the gonadotropin-releasing hormone and gonadotropin secretion, steroidogenesis, folliculogenesis, and implantation, and serve as promising markers of assisted reproductive technology program outcomes.
AIM: The aim of this study was to evaluate the dynamics of blood adipokine levels and their ratios during the controlled ovarian hyperstimulation in assisted reproductive technology programs depending on the onset of clinical pregnancy.
MATERIALS AND METHODS: This study involved 51 patients undergoing infertility treatment using assisted reproductive technology in a short protocol with gonadotropin-releasing hormone antagonists. Depending on the onset of clinical pregnancy, two study groups were formed: non-pregnant (group 1, n = 22) and pregnant (group 2, n = 29). Blood leptin, adiponectin, and ghrelin levels were assessed using enzyme immunoassay at three points: assisted reproductive technology protocol start-up, the day of oocyte pick-up, and the day of embryo transfer.
RESULTS: On the day of oocyte pick-up, patients in group 1 had higher leptin levels (5.47 ± 1.92 vs. 3.76 ± 0.75 ng/ml; p = 0.0004), leptin/adiponectin ratios (11.45 ± 4.50 vs. 4.73 ± 1.08; p < 0.001), and leptin/ghrelin ratios (0.43 ± 0.17 vs. 0.24 ± 0.07; p < 0.001). On the day of embryo transfer, patients in group 1 had higher levels of leptin (6.37 ± 2.13 vs. 3.29 ± 1.21 ng/ml; p < 0.001) and adiponectin (0.75 ± 0.22 vs. 0.60 ± 0.09 ng/ml; p = 0.001), as well as ratios of leptin/adiponectin (9.06 ± 3.73 vs. 5.59 ± 2.32; p < 0.001), leptin/ghrelin (0.48 ± 0.15 vs. 0.20 ± 0.07; p < 0.001), and adiponectin/ghrelin (0.06 ± 0.02 vs. 0.04 ± 0.01; p < 0.001).
CONCLUSIONS: The data obtained indicate that blood adipokine levels change during the controlled ovarian hyperstimulation in assisted reproductive technology protocols depending on clinical pregnancy and can be used to predict its onset.



Human leukocyte antigen, isotype DR (HLA-DR) expression in the normal endometrium and in endometrial pathology
Abstract
BACKGROUND: Human leukocyte antigen, isotype DR (HLA-DR) expression is associated with inflammatory and autoimmune diseases. It is also found on the surface of tumor cells. The role of HLA-DR in endometrial pathology has not been sufficiently studied.
AIM: The aim of this study was to determine HLA-DR expression features in the endometrium under normal and pathological conditions.
MATERIALS AND METHODS: We performed immunohistochemical examination of endometrial biopsy specimens, namely, 18 cases of endometrioid carcinomas, 139 cases of chronic endometritis, and 37 cases of endometrial polyps. The control group included 50 cases of the endometrium without pathology. Positive HLA-DR expression was detected as brown staining of varying intensity of immune cells of the cytogenic stroma, as well as the cytoplasm and membranes of endometrial epithelial cells. The average number of positively stained stromal cells in ten visual fields was counted. HLA-DR expression in the cytoplasm and on the membrane of endometrial epithelial cells was assessed semi-quantitatively as weak (low) (with staining up to 50% of the glands) or pronounced (high) (with staining more than 50% of the glands).
RESULTS: HLA-DRim expression was detected on immune cells of the cytogenic stroma of the endometrium in all of the study groups. HLA-DR expression in the endometrial epithelium was characterized by two main immunophenotypes — negative and positive. Negative HLA-DR expression was found in 55.6% of endometrial cancer cases, in 25.2% of chronic endometritis cases, in 27.7% of endometrial polyp cases, and in all cases of the normal endometrium. The positive HLA-DR (high) immunophenotype was found in 21.6% of chronic endometritis cases, in 28.6% of endometrial polyp cases, and in 16.7% of endometrial cancer cases. Pronounced HLA-DR expression in the epithelium was associated with a high HLA-DR level in the cytogenic stroma and a significantly frequent detection of HLA-DR+ lymphoid follicles in endometrial cancer. The positive HLA-DR (low) immunophenotype was established in 51.8% of chronic endometritis cases and in 27.8% of endometrial polyp cases, and in 27.7% of endometrial cancer cases, and was associated with low HLA-DR levels in the stroma.
CONCLUSIONS: The revealed heterogeneity of HLA-DR expression in chronic inflammation and endometrial cancer allows for distinguishing two main immunophenotypes of endometrial cancer, namely, with negative and positive HLA-DR expression. HLA-DR may be an early predictor of adverse background endometrium and endometrial cancer. The positive HLA-DR immunophenotype of endometrial cancer probably indicates a specific mechanism of carcinogenesis associated with chronic inflammation and requires further comprehensive clinical, morphological and molecular genetic research.



Reviews
Regulation of ovarian function in obese women: pathogenetic mechanisms
Abstract
Considering the universally high rates of obesity among the population, including women of reproductive age, and the negative impact of obesity on female fertility, the interest in this problem in the modern world becomes understandable. Many researchers have confirmed the pattern of ovulatory dysfunction development because of metabolic disorders in obese women. The exact mechanism for the development of anovulation and infertility in women with obesity has not been established, however, many pathogenetic factors that affect reproductive function are already known. Obese women have a high risk of developing ovulatory dysfunction due to insulin resistance, hyperandrogenism, as well as subclinical inflammation, lipotoxicity, and disruption of adipokines due to excess adipose tissue, which generally leads to impaired steroidogenesis and regulation in the hypothalamic – pituitary – gonadal axis. Due to the high prevalence of obesity in women of reproductive age, the objective of this review was to examine the pathogenetic mechanisms of the impact of obesity on female fertility, as well as the impact of high body mass index on the results of assisted reproductive technology (ART) cycles. We carried out a literature search in the PubMed database for the entire period of publications using phrases such as “ovarian function + obesity,” “pathogenesis of ovarian dysfunction in obesity,” “ART + obesity,” and “perinatal outcomes + bariatric surgery”. The most relevant studies being selected, with domestic and foreign clinical recommendations used in preparing the manuscript.



Possibilities of an experimental approach in creating fetal growth restriction in animal models
Abstract
The literature review was compiled to assess which animal models of intrauterine development disorders most adequately reflect the pathological processes in the clinic.
Intrauterine growth restriction associated with placental insufficiency is an urgent scientific and practical problem of modern obstetrics and perinatology. According to World Health Organization, this complication occurs in 10% of pregnant women. The etiology and mechanisms of this pathology have been the focus of research for more than decades. Nevertheless, the methods of predicting and preventing this pathology are not very effective, as consensus in diagnostic approaches is only being formed, and there are practically no methods of correction. The results of experimental studies have made a significant contribution to the understanding of the pathophysiological foundations of the placental insufficiency and intrauterine growth restriction development. For this purpose, various laboratory animals are used, most often rats (Rattus norvegicus), chinchillas (Chinchilla lanigera), mice (Mus musculus), rabbits (Oryctolagus cuniculus), and guinea pigs (Cavia porcellus). Each of the above types of experimental animals has its own advantages for studying intrauterine growth restriction. There are three main methods used to simulate intrauterine growth restriction in animals: the surgical method (ligation of blood vessels), the method of placing in a chamber with a reduced oxygen concentration, and the method of lowering the caloric content and amount of food.
Various models of intrauterine growth restriction have been proposed over a long study of the problem. However, these data differ greatly among themselves in the literature. The task of this review was to understand the most effective models and animal species to study fetal growth retardation, as well as ways to create this pregnancy complication.



Morphofunctional features of the fallopian tubes. Modern concepts
Abstract
The article provides an overview of the modern literature covering the role of the fallopian tubes in reproduction.
The understanding of the anatomy and functions of the fallopian tubes has changed several times over the centuries. There is still no generally accepted opinion regarding some of the features of their structure. The normal functioning of the fallopian tubes is possible only due to the complex interaction of physical and biochemical processes occurring therein. In recent years, many discoveries have been made regarding the fallopian tubes that showed that we still do not know all the details of how this organ works. There are several basic methods for assessing the functions of the fallopian tubes, but all of them have their drawbacks and are of limited use, which is why it can sometimes be quite difficult to get a complete picture of the organ’s functioning. Modern discoveries and the introduction of new techniques into practical work can significantly expand the doctor’s capabilities in treating infertility associated with the tubal factor.
The current knowledge about the anatomical, functional and morphological features of the fallopian tubes emphasizes the importance of this organ in the implementation of the woman’s reproductive function. It is generally believed that the role of the fallopian tubes in conception is secondary and unimportant in comparison with the tasks performed by the uterus and ovaries. The importance of the fallopian tubes is most often mentioned in the literature in no more than a few paragraphs, where it is said only that the egg moves through them to the uterine cavity. However, modern research proves that complex processes and interactions occur in the organ that maintain homeostasis therein. After all, only the totality of the preserved function of each of the organs of the female reproductive system can ensure the onset and prolongation of future pregnancy.



Modern view of the causes of antenatal fetal death
Abstract
About two million cases of prenatal fetal death are recorded annually, that is, a stillborn baby is born every 16 seconds. However, even such impressive data does not reflect the full scale of the problem. The WHO data does not include stillbirth rates at 22–28 weeks, which some studies estimate would increase the rate by about 40%. The difference in stillbirth rates in developed and developing countries indicates the quality of medical care and, as a result, the country’s medical system. According to the Federal State Statistics Service, the stillbirth rate in the Russian Federation accounts for a large share of perinatal loss (79%) and does not have a downward trend. Besides, there is currently no unified classification of the causes of prenatal fetal death, which complicates the analysis of stillbirth cases and possible reserves for their reduction. It is noteworthy that the proportion of cases with an unknown cause of perinatal mortality is growing (3.1% in 2019 and 4.7% in 2020). Despite the fact that the rate of unexplained causes of antenatal fetal death in the Russian Federation is almost three times lower than abroad, the large proportion of causes associated with fetal asphyxia deprives these data of specificity. Against the backdrop of the demographic crisis in the Russian Federation (the birth rate for 2022 was 1.4), identifying risk factors for antenatal fetal death is especially acute, since this underlies the creation of preventive measures to reduce the risk of adverse obstetric outcomes.



Clinical practice guidelines
Perinatal outcomes after surgical treatment of cervical LSIL and conservative treatment of endometrial cancer. A clinical case analysis
Abstract
This article describes a clinical case of pregnancy management in a patient after surgical treatment of low-grade squamous intraepithelial lesions (LSIL) of the cervix and endometrial cancer. In the structure of female oncological morbidity, precancerous conditions and malignant diseases of the female genital organs occupy leading positions and require the most sparing treatment in women who have not realized reproductive function. The frequency of miscarriage in early pregnancy associated with a history of endometrial cancer, requiring repeated invasive manipulations to assess the effectiveness of treatment, reaches 36–40%, depending on the age of the woman. After surgical interventions on the cervix, regardless of the method of exposure, the frequency of miscarriage significantly increases due to the formation of an organic form of isthmic-cervical insufficiency, which dictates the need for preventive cervical circumcision in a regulated time. In addition, the results of numerous studies also indicate an infectious cause as the main etiological factor in the development and progression of isthmic-cervical insufficiency. Management tactics, obstetric risks, as well as the possibilities of choosing a treatment method are discussed on the basis of the presented clinical case.



Giant biliary cyst rupture during pregnancy. A case report
Abstract
Biliary-hepatic cyst is a rare benign cystic neoplasm that in most cases occurs inside the intrahepatic bile ducts. Clinical signs and symptoms are non-specific, and there is no single treatment strategy. Modern highly informative imaging methods, such as ultrasound, computed tomography and magnetic resonance imaging, in most cases allow the diagnosis of biliary cysts, however, during pregnancy, especially in the second and third trimesters, diagnosis can be significantly complicated due to the large size of the uterus.
The article presents a rare case of biliary cyst rupture in a pregnant woman diagnosed during laparotomy. The patient was admitted for emergency surgery with a preliminary diagnosis of a rupture of a giant ovarian cyst. During the surgery, it was found that a biliary cyst emanating from the liver had ruptured, followed by the development of biliary peritonitis, which required the involvement of an abdominal surgeon to excise the cyst capsule along with the gallbladder. For further treatment, the patient was transferred to a specialized surgical department of a multidisciplinary hospital. The course of the postoperative period passed without complications. The patient was discharged from the hospital in a satisfactory condition on the 10th day.



Towards the modern theory of parturition
Abstract
A system analysis of the results of modern scientific research has shown the most complex organization of the parturition, during which the unfolding and activation of the genetic birth program initially embedded in the mother and child occurs. 2–3 weeks before birth, desympatization and formation of an acupuncture network begin in the uterus. Along these acupuncture channels the wave flows of biologically active substances with both contractile and inhibitory properties move. These substances are delivered to the uterus by the bloodstream and blood cells. Some of them also have psychotropic properties, thereby enhancing the effect on the brain and causing a state of altered consciousness in the woman and her child. As labor approaches, the prenate revealed activation of the locus on chromosome 2, which allowed the researchers to assert that the prenate is initiator of the birth beginning. The totality of the data presented in the article served as a prerequisite for the formulation of a scientifically substantiated Theory of the parturition, according to which childbirth is a genetic-psychosomatic phenomenon, free of pain.


